secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azitra, Inc. (AZTR)
CIK:        0001701478
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001493152-23-021998
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azitra completes IPO of 1.5M shares at $5.00; net proceeds ~$6.5M for clinical development
--------------------------------------------------------------------------------

- Offering of 1.5M shares at $5.00/share; gross proceeds $7.5M, net ~$6.5M after expenses.
- Underwriters have 45-day option to buy up to 225K additional shares for over-allotments.
- Representative's warrants issued for up to 60K shares at $6.25, exercisable Dec 2023 – Jun 2028.
- Net proceeds to fund clinical trials, R&D, clinical manufacturing, and general corporate purposes.
- Amended and restated certificate of incorporation and bylaws became effective upon closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701478/000149315223021998/0001493152-23-021998-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701478/000149315223021998/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021998

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer